Skip to content
Antivirals — Hepatitis C direct-acting antiviralsATC J05AP55

Sofosbuvir–velpatasvir

Prescription onlyWHO essential medicine

12-week pill that cures hepatitis C.

Starts working
Varies
Half-life
About 15 hours (velpatasvir)
In use since
2016
Pregnancy
Use with caution

Overview

This combination cures more than 95% of people with chronic hepatitis C, whatever the virus genotype, in a 12-week course of one tablet a day. It transformed a disease that once needed a year of injections with poor results.

Conditions it's used for

How it works

Blocks two proteins the hepatitis C virus needs to copy itself.

Sofosbuvir–velpatasvir belongs to the Hepatitis C direct-acting antivirals. How Hepatitis C direct-acting antivirals work: block two separate proteins the hepatitis C virus needs to copy itself.

Uses

  • Chronic hepatitis C (all genotypes)

Available as: tablet.

Typical dose

Adults
One tablet (400/100 mg) once a day for 12 weeks.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Headache
  • Tiredness
  • Nausea

Serious — get medical help

Uncommon, but need prompt attention

  • Severe slow heart rate with amiodarone
  • Hepatitis B reactivation

Warnings

  • Test for hepatitis B first
  • Separate from antacids; avoid regular PPIs unless managed

Interactions

  • Amiodarone — dangerous bradycardia
  • PPIs and H2 blockers — reduce absorption
  • Rifampicin, carbamazepine — contraindicated
Check Sofosbuvir–velpatasvir against your own medicines

Pregnancy and breastfeeding

Use with caution

Not routinely used in pregnancy yet; data emerging.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Epclusa
United Kingdom
Epclusa
India
Velpanat, Myhep All

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

In 2014 sofosbuvir launched in the US at about $1,000 a pill; Indian generics later brought a full cure to under $100 in many countries.

Common questions

Can I get hepatitis C again?

Yes — cure doesn't give immunity, so avoiding reinfection matters.

Do I need a prescription for Sofosbuvir–velpatasvir?

Yes — Sofosbuvir–velpatasvir is prescription-only in most countries.

Can I take Sofosbuvir–velpatasvir during pregnancy?

Use with caution. Not routinely used in pregnancy yet; data emerging. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.